am 251 and neurotensin
am 251 has been researched along with neurotensin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adermark, L; Lovinger, DM; Yin, HH | 1 |
| Kawahara, H; Mitchell, VA; Vaughan, CW | 1 |
Other Studies
2 other study(ies) available for am 251 and neurotensin
| Article | Year |
|---|---|
Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling.
Topics: Animals; Animals, Newborn; Cannabinoid Receptor Modulators; Corpus Striatum; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Endocannabinoids; Excitatory Postsynaptic Potentials; In Vitro Techniques; Neurons; Neurotensin; Patch-Clamp Techniques; Piperidines; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2008 |
Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
Topics: Adamantane; Animals; Cannabinoid Receptor Modulators; Endocannabinoids; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Imidazoles; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Miniature Postsynaptic Potentials; Neural Inhibition; Neurons; Neurotensin; Pain; Periaqueductal Gray; Piperidines; Presynaptic Terminals; Pyrazoles; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Neurotensin; Synaptic Transmission; Tetrodotoxin; Time Factors | 2009 |